Healthcare -
Biotechnology - NASDAQ - GB
$ 0.53
-1.85 %
$ 22.6 M
Market Cap
-3.12
P/E
ADAP - TOTAL OTHER INCOME
Total Other Income ADAP - Adaptimmune Therapeutics plc
25.5 M
LAST VALUE
127.05%
2 YEAR CAGR
32.05%
5 YEAR CAGR
134.84%
10 YEAR CAGR